Nestle to Sell Vitamins Business for $1 Billion

Nestle has agreed to sell its mainstream vitamins, minerals, and supplements business to U.S.-based Yellow Wood Partners for $1 billion. The transaction encompasses seven brands and the company's U.S. private-label supplements operations.

This divestment is part of broader strategic shifts within Nestle Health Science. The company plans to integrate Nestlé Health Science into a unified Nutrition division, a move that will also see the departure of Nestlé Health Science CEO Anna Mohl from the Executive Board. Nestle aims to concentrate on high-growth, science-backed premium segments, reorganizing its portfolio around four key units: Petcare, Coffee, Nutrition (including Health Science), and Food & Snacks.

Recent developments from Nestle Health Science include the February 2026 launch of Nestlé Vital, a new line of nutritional beverage powders for adults over 40, targeting muscle strength, energy, and cognitive health. The company also released clinical study results on NAD+ boosters and announced a partnership with Australian Catholic University to establish a start-up incubator for nutrition innovations. In the 2025 financial year, Nestle Health Science reported 3.2% organic growth and 3.5% real internal growth. Earlier in 2026, a global precautionary recall of certain infant formula batches was conducted due to potential contamination.